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Nef transcripts were analyzed from peripheral blood mononuclear cells of 10 HIV-1-infected subjects with 9-822 CD4/
lymphocytes/cu mm, including 4 individuals with a probable common source infection. There was no relationship between
the phylogenetic position of the various nef sequences and the disease state of the person from whom they were derived.
The nef open reading frame was disrupted in all three clones from only 1 subject. Functional analyses of a representative
clone from each of the remaining 9 subjects showed that all nef alleles were capable of CD4 cell surface down-regulation,
but only three nef alleles suppressed the induction of IL-2 transcription. q 1996 Academic Press, Inc.
The HIV/SIV nef genes have been suggested to play has been shown to be an SH3-binding motif allowing
interaction of Nef with Hck (13). Nef has been localizeda critical role in regulating virus load and pathogenicity
in vivo (Ref. 1 for review; 2). It has been known for some to various subcellular sites including the plasma mem-
brane, cytoplasm, cytoskeleton, as well as the nucleustime that introduction of a deletion in the nef gene in
the pathogenic SIVmac239 clone resulted in a virus that (14–17).
Nef has diverse activities in cultured cells that may orreplicated to equivalent levels as the parental clone in
tissue culture, but manifested a dramatically lower virus may not be relevant to its effect on virus load in vivo. Nef
downregulates CD4 cell surface expression by disruptingload in infected rhesus macaque monkeys (2, 3). More
recently, Du et al. have reported that substitution of two the association with Lck, and increasing the rate of CD4
internalization (18–22). Nef can affect T cell activationcodons of the SIVmac239 nef with those found in an
acutely lethal viral variant, SIVsmPBj14, converted SIV- pathways involving tyrosine phosphorylation and IL2 acti-
mac239 infection to an acutely lethal phenotype (4). Fur- vation, and these effects appear to depend on the subcel-
ther support for the critical role of nef in vivo was derived lular location of Nef (23–27). Whereas Nef may downreg-
from studies of long term nonprogressing HIV-1-infected ulate HIV-1 replication, principally in T cell lines, a posi-
subjects, who have low virus loads (5, 6). A subset of tive effect on HIV infectivity has been demonstrated,
these individuals manifested deletions of large portions primarily in quiescent T cells (28–34). In addition, Nef
of the nef gene. Taken together, these data indicate that has transforming activity toward NIH 3T3 cells and can
the nef gene product plays a pivotal role in HIV pathogen- interact with tyrosine and serine protein kinases (4, 35).
esis. Various alleles of nef have been shown to differ in
The HIV-1 Nef protein is 206 amino acids in length (7; these biological activities (36). In order to determine if
Fig. 1). It has a conserved myristylation acceptor glycine particular nef alleles are associated with progressive
encoded by codon 2 (8). Potential protein kinase C phos- HIV-1 infection, the current study examined nef alleles
phorylation sites at positions 15 and 80 have been identi- from a cohort of patients at various stages of disease.
fied (9–12). A (proline-x-x)4 sequence at positions 69–80 For the current study, we chose to examine HIV-1 tran-
scripts from uncultured peripheral blood mononuclear
cells (PBMCs) to focus on actively expressed genes, in
1 To whom correspondence and reprint requests should be ad- contrast to other studies which have utilized DNA from
dressed. Fax: (314) 454-1792. E-mail: LRATNER@IMAGATE.WUS
infected PBMCs or viral genomic RNA isolated from viri-TL.EDU.
ons in the plasma. For this purpose, blood was collected2 Current address: New York University School of Medicine, New
York, NY 10016. between Oct, 1991 and May, 1994 from 50 randomly se-
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FIG. 1. Comparison of Nef sequences from HIV-1-infected subjects. A consensus amino acid sequence is provided for each of the 10 subjects
derived from one of the three nucleotide sequences (Sj) in the current study. Gaps are introduced to maximize the alignment, and dots indicate
positions at which deletions are present relative to other Nef sequences. Numbers above the lines indicate amino acid positions, based on the
sequence from subject 1. Shaded residues are those that differ from the sequence shown for subject 1. The myristylation acceptor site (MYR),
potential sites for protein kinase c phosphorylation (PKC), acidic residues (ACIDIC), SH3-binding sequences (PxxPxxPxxPxx), and a critical residue
for protein kinase association (KIN) are indicated. The absolute number of CD4 cells per cu mm of blood is shown for each patient at the time of
sample collection, and the change in CD4 counts (DCD4) over the subsequent time period (3–42 months, median 14 months) is expressed as cell
number/cu mm/month. CAT indicates the ratio of IL2 CAT activity in the presence compared to the absence of coexpression of the particular nef
allele under the control of the CMV promoter (range 0.07–1.00), normalized to the ratio of RSV CAT activity measured in the presence compared
to the absence of coexpression of the nef allele (range 0.84–1.00) in Jurkat-25 cells. CAT values 0.15 are highlighted with shading. CD4s is the
mean channel fluorescence value of CD4 in FACS analyses in two separate experiments where Jurkat-25 cells were transfected with the nef allele
expressed under the control of the CMV promoter; when cells were transfected with the vector lacking nef sequences, the mean channel fluorescence
values were 106 and 119, respectively. NA, not available.
lected patients whose CD4 lymphocytes were between that there was no DNA contamination. Reactions were
monitored with in vitro-synthesized nef transcripts, and9 and 822 per cu mm (Fig. 1). Subjects 1–4 in the current
study were identified in follow-up studies as likely sexual the sensitivity of these reactions was consistently 100
copies of RNA. The 10 patients from whom nef transcriptspartners, and thus probably sharing a common source
isolate. PBMCs were purified by Ficoll Hypaque gradient were detected by this methodology were utilized for fur-
ther analysis. It is conceivable that recovery of nef cDNAscentrifugation, and cells were washed twice with phos-
phate-buffered saline (PBS), and cryopreserved at 0757. from this patient subset may be the result of higher viral
loads.Poly(A/) RNA was isolated using the Micro-Fast Track
procedure (Invitrogen, CA) and treated with RNase-free Multiple tubes containing nef RT-PCR products were
pooled and products electrophoresed on agarose gels.DNase I before reverse transcription (RT; Ref. 37). Nested
PCR was performed as previously described using prim- The 0.8-kb products were recovered by gel interception
using DEAE membranes followed by elution of DNA fromers S7B and NefAS for the first round which span a splice
junction, and Nef8306 and Nef9134 in the second round the membrane with high salt and ethanol precipitations.
DNA products were digested with SacI and HindIII, re-(37). Controls were performed without RT to further insure
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striction sites incorporated into the PCR primers, and tution of residue 138. This finding appears to contradict
the conclusion of Premkumar et al. that this substitutioncloned into pUC19 digested with the same enzymes.
DNA was transformed into DH5alpha Escherichia coli, is associated with a nonprogressor phenotype (47).
The evolutionary relationships of the newly derivedand three distinct positive plasmids for each patient were
isolated. Primers spanning different overlapping areas of nef sequences were also examined by phylogenetic tree
analyses. As expected for viral strains infecting the sameboth strands of the amplified products were utilized for
sequence analysis with Sequenase (USB) and a[35S]- individual, sequences derived from the same blood sam-
ple formed monophyletic clusters (Fig. 2A). This findingdATP. Genbank accession numbers for these sequences
are U44443–U44472. excludes the possibility of cross-contamination of viral
sequences. In addition, sequences from four individualsThe phylogenetic relationships of the newly derived
nef sequences were determined essentially as pre- (subjects 1–4) formed a tight cluster (supported by high
bootstrap values), suggesting that they represented epi-viously described (38). Nucleotide sequences were
aligned using CLUSTAL (39) with minor manual adjust- demiologically linked infections. None of the other nef
sequences were particularly closely related to each otherments to optimize alignments. Pairwise evolutionary dis-
tances were estimated using Kimura’s two-parameter or to other representatives of subtype B (Fig. 2B).
A representative clone from each subject (excludingmethod (40) to correct for superimposed substitutions.
Ambiguous areas and sites where there was a gap within those from subject 6, Fig. 1) was selected for functional
analyses, cloned in pCB6neo (9). Ten micrograms ofthe sequence alignment were excluded from all compari-
sons. Phylogenetic trees were constructed by the neigh- each CMV expression clone were transfected into Jurkat-
25 cells using DEAE dextran. Controls included CMV-bor-joining method (41), and their reliability was esti-
mated from 1000 bootstrap replicates (42). These meth- nef, as well as CMV-fen, in which the HXB3 nef sequence
was inserted into pCB6neo in the antisense orientation.ods were implemented using CLUSTAL W (43).
Nucleotide sequences were obtained from three Additional controls included Jurkat 133 and Jurkat 22F6
cells that were stably transfected with NL4-3 nef ex-clones for each subject, and these 30 sequences were
all distinct. Four sequences, two each from subjects 2 pressed from the HTLV1 promoter in pSRa or the plasmid
without a nef sequence, respectively (9). After 48–72 hr,and 3, had extensive deletions (nucleotides 1–510, 11 –
602, 400–618, and 400–618) and were excluded from the cells were washed twice with PBS, passed through
a 21-gauge needle, and boiled. Expression of Nef in thefurther analyses. Intrapatient sequence heterogeneity
was lower than interpatient heterogeneity, providing evi- transfected cells was examined by 12% SDS–PAGE gels
and immunoblots using rabbit a-Nef antibody and thedence that cross-contamination of samples did not occur
(Fig. 2a). ECL method using HRP-labeled antibody and color devel-
opment with alkaline-phosphatase-labeled a-rabbit IgGRepresentative deduced amino acid sequences for
each full-length Nef sequence of the 10 subjects is (Promega). No significant differences in the levels of Nef
protein expression were seen with the different nef al-shown in Fig. 1. A variable duplication was found at
position 21, as previously described (12, 44). All three leles (not shown). This is to be contrasted with the find-
ings of Zazopoulos and Haseltine who identified two nat-clones from subject 6 showed a substitution of the initia-
tor methionine codon with isoleucine and the presence urally occurring Nef proteins with point mutations that
resulted in unstable products (48).of a termination codon at position 113. Thus, it is un-
likely that a Nef protein was expressed from these tran- Effects of Nef on CD4 cell surface expression were
measured by cotransfection into Jurkat cells with eitherscripts, and these sequences were not utilized in the
functional analyses. This subject was infected with HIV- a plasmid expressing a fusion protein of the vesicular
stomatitis virus glycoprotein (VSV G) with the cyto-1 for at least 4 years prior to this study and has had no
opportunistics infections or antiviral therapy. In a study plasmic domain of CD4 (G-CD4), or a plasmid express-
ing the VSV G protein (18). Cell surface protein expres-by Michael et al., only 2 of 88 nef sequences from 9 HIV-
1-infected subjects had gross alterations of the open sion was evaluated by flow cytometry using a rabbit
anti-VSV G antibody and a FITC-goat anti-rabbit anti-reading frame (45).
Functionally important domains of the Nef protein were body, and the mean channel fluorescence was calcu-
lated based on a 256-channel histogram. All nef alleleswell conserved (Fig. 1), including the myristylation ac-
ceptor site at position 2, the SH3-binding (Pxx)4 sequence from this study showed similar levels of CD4 down-
regulation, with mean channel fluorescence expression(13), and Arg-105 which is important for association with
a protein kinase (46). A potential protein kinase C phos- levels of 35 – 51 in the presence of Nef, compared to
levels of 106 and 119 in two separate experiments inphorylation site was present at position 15 in Nef se-
quences from 5 subjects, whereas the site at position the absence of Nef (Fig. 1). This is to be contrasted with
the results of Michael et al., who found 22 and 18% of80 was fully conserved (9, 12). Subject 10, with 9 CD4
lymphocytes/cu mm, was found to have a cysteine substi- nef alleles were defective or partially defective, respec-
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FIG. 2. Phylogenetic trees for Nef sequences. (a) Phylogenetic relationships of nef sequences generated in this study. Horizontal lengths are
drawn to the scale (the scale bar represents 0.01 nucleotide substitutions per site); vertical separations are for clarity only. The tree was rooted
using SIVcp2GAB as an outgroup. (b) Phyogenetic relationships of nef sequences described in (a) to nef sequences reported by other investigators.
Nef sequences of the present study are designated 1A–10A, and correspond to the sequences shown in (a). S1–S9 have been reported by Shugars
et al. (12); similarly, sequences LSS, BO, SF, LM, D, RP, CD, RR, E, and DH have been reported by Huang et al. (49); all other sequences are derived
from the HIV database (7). The tree was rooted by reference to SIVcp2 as an outgroup.
tively, for CD4 downregulation (45). Michael et al. found (Fig. 1). No single amino acid change could be identified
as responsible for this effect.no significant differences among slow, intermediate, or
rapid progressors (45). Effects of each nef allele on virus infectivity were deter-
mined in trans, by cotransfection of the nef expressionEffects of Nef alleles on T-cell activation were mea-
sured by cotransfection with RSV-CAT or IL2-CAT DNAs, clones into 293T cells with a nef-deleted proviral clone
at a ratio of 18:1, as previously described (51). After 48in PMA-treated or untreated Jurkat-25 cells, as previously
described (24, 25). The level of IL-2 promoter induction hr, equivalent amounts of p24 antigen from each virus
preparation (5 ng) were used to infect MAGI cells, andwas normalized to that obtained with the RSV promoter,
in the presence compared to the absence of the nef after an additional 48 hr, the cells were fixed, incubated
with X-gal, and infectious centers were quantitated. Oneexpression clones. Expression clones from three sub-
jects (subjects 3, 5, and 10) resulted in 85% suppres- nef clone, from subject 8, consistently increased the
number of infectious centers twofold, whereas the ex-sion of IL-2 induction, whereas no significant inhibitory
effects were seen with clones from the other six subjects pression clones from the other eight subjects had no
AID VY 8098 / 6a1D$$$461 08-03-96 20:59:12 viras AP: Virology
249SHORT COMMUNICATION
ics Group, Los Alamos National Laboratory, Los Alamos, NM,significant effects on virus infectivity in this assay (not
1995.shown).
8. Allan, J. S., Coligan, J. E., Lee, T-H., McLane, F., Kanki, P. J., Groop-
The current study confirms and extends previous work man, J. E., and Essex, M., Science 230, 810–813 (1985).
demonstrating heterogeneity among nef alleles in se- 9. Bandres, J. C., Luria, S., and Ratner, L., Virology 201, 157–161
quence as well as function (45, 52). As reported pre- (1994).
10. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M.,viously (45), there was no relationship between the phylo-
Montagnier, L., and LeCocq, J-P., Nature 330, 266–269 (1987).genetic position of the various nef sequences and the
11. Guy, B., Riviere, Y., Dott, K., Regnault, A., and Kieny, M. P., Virologydisease stage of the patients from which they were de-
176, 413–425 (1990).
rived. This is true for nef transcripts, as well as nef gene 12. Shugars, D. C., Smith, M. S., Glueck, D. H., Nantermet, P. V., Seillier-
sequences from integrated proviruses. Moiseiwitsch, F., and Swanstrom, R., J. Virol. 67, 4639–4650
(1993).Interestingly, sequences from subjects 1–4 formed a
13. Saksela, K., Cheng, G., and Baltimore, D., EMBO J. 14, 484–491tight cluster in phylogenetic trees (Fig. 2), which led us
(1995).to investigate a possible epidemiological linkage. We
14. Franchini, G., Robert-Guroff, M., Ghrayeb, M. J., Chang, N. T., and
found that three of these four subjects were sexual part- Wong-Staal, F., Virology 155, 593–599 (1986).
ners, and the fourth individual lived in the same locale 15. Murti, K. G., Brown, P. S., Ratner, L., and Garcia, J. V., Proc. Natl.
and was possibly a sexual partner with one or more of Acad. Sci. USA 90, 11895–11899 (1993).
16. Niederman, T. M. J., Hastings, W. R., and Ratner, L., Virology 197,the other three individuals.
420–425 (1993).Sequences from only one subject manifested a disrup-
17. Yu, G., and Felsted, R. L., Virology 187, 46–55 (1992).tion of the nef open reading frame (subject 6, Fig. 1).
18. Bandres, J. C., Shaw, A. S., and Ratner, L., Virology 207, 338–341
Since only three clones from this individual were ana- (1995).
lyzed, it is possible that a minor transcript from an intact 19. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., and Trono, D.,
Cell 76, 853–864 (1994).nef open reading frame coexisted in this individual with
20. Garcia, J. V., Alfano, J., and Miller, A. D., J. Virol. 67, 1511–1516the defective nef sequences. This individual had an inter-
(1993).mediate CD4 lymphocyte count (423 CD4 lymphocytes/
21. Garcia, J. V., and Miller, A. D., Nature 350, 508–511 (1991).
cu mm). It has recently been suggested that long-term 22. Salghetti, S., Mariani, R., and Skowronski, J., Proc. Natl. Acad. Sci.
nonprogressors often harbor defective nef sequences. USA 92, 349–353 (1995).
This finding has been taken to indicate that defective nef 23. Baur, A. S., Sawai, E. T., Dazin, P., Fanti, W. J., Cheng-Mayer, C.,
and Peterlin, B. M., Infect. Immun. 1, 373–384 (1994).gene sequences correlate with nonprogressive infection.
24. Bandres, J., and Ratner, L., J. Virol. 68, 3243–3249 (1994).While this may be the case in a selected number of
25. Niederman, T. M. J., Garcia, J. V., Hastings, W. R., Luria, S., andcases, we believe that nef is not a major determinant of
Ratner L., J. Virol. 66, 6213–6219 (1992).
HIV pathogenicity. 26. Luria, S., Chambers, I., and Berg, P., Proc. Natl. Acad. Sci. USA 88,
5326–5330 (1991).
27. Skowronski, J., Parks, D., and Mariani, R., EMBO J. 12, 703–713ACKNOWLEDGMENTS
(1993).
This work was supported by PHS Grants AI24745, 25903 and grants 28. Luciw, P. A., Cheng-Mayer, C., and Levy, J. A., Proc. Natl. Acad.
from AMFAR and the McDonnell Douglas Employees Community Fund. Sci. USA 84, 1434–1438 (1987).
29. Ahmad, N., and Venkatesan, S., Science 241, 1481–1485 (1988).
30. Niederman, T. M. J., Thielan, B. J., and Ratner, L., Proc. Natl. Acad.
REFERENCES Sci. USA 86, 1128–1132 (1989).
31. Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R., and Greene,1. Ratner, L., and Niederman, T. M. J., Curr. Top. Microbiol. Immunol.
W. C., Proc. Natl. Acad. Sci. USA 86, 9549–9553 (1989).193, 169–208 (1995).
32. Miller, M. D., Wamerdam, M. T., Gaston, W. C., Greene, W. C., and2. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K.,
Feinberg, M. B., J. Exp. Med. 179, 101–113 (1994).Danield M. D., and Desrosiers, R. D., Cell 65, 651–662 (1991).
33. Aiken, C., and Trono, D., J. Virol. 69, 5048–5026 (1995).3. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Seghal, P. K., and Desro-
34. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J. S., Richman,siers, R. C., Science 258, 1938–1941 (1993).
D. D., and Guatelli, J. C., J. Virol. 68, 2906–2914 (1994).4. Du, Z., Lang, S. M., Sassevile, V. G., Lackner, A. A., Ilyinskii, P. O.,
35. Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A., andDaniel, M. D., Jung, J. U., and Desrosiers, R. C., Cell 82, 665–
Cheng-Mayer, C., Proc. Natl. Acad. Sci. USA 91, 1539–1543674 (1995).
(1994).5. Kirchoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and
36. Terwilliger, E. F., Langhoff, E., Gabuzda, D., Zazopoulos, E., andDesrosiers, R. C., N. Engl. J. Med. 332, 288–232 (1995).
Haseltine, W. A., Proc. Natl. Acad. Sci. USA 88, 10971–109756. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting,
(1991).M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A.,
37. Arens, M., Joseph, T., Nag, S., Miller, J. P., Powderly, W. G., andChatfield, C., Lawson, V. A., Crowe, S., Maerz, A., Sonza, S.,
Ratner, L., AIDS Res. Hum. Retroviruses 9, 1251–1257 (1993).Learmont, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton,
D., Mills, J., Science 270, 988–991 (1995). 38. Gao, F., Morrison, S. G., Robertson, D. L., Thornton, C. L., Craig,
S., Karlsson, G., Sodroski, J., Morgado, M., Galvao-Castro, B.,7. Myers, G., Korber, B., Hahn, B. H., Jeang, K-T., Mellors, J. W., McCut-
chan, F. E., Henderson, L. E., and Pavlakis, G., ‘‘Human Ret- von Briesen, H., Beddows, S., Weber, J., Sharp, P. M., Shaw,
G. M., Hahn, B. H., and WHO and NIAID Network for HIV isolationrovirues and AIDS: A Compilation and Analysis of Nucleic Acid
and Amino Acid Sequences.’’ Theoretical Biology and Biophys- and characterization. J. Virol. 70, 1651–1667 (1996).
AID VY 8098 / 6a1D$$$461 08-03-96 20:59:12 viras AP: Virology
250 SHORT COMMUNICATION
39. Higgins, D. G., and Sharp, P. M., Comput. Appl. Biosci. 5, 151–153 48. Zazopoulos, E., and Haseltine, W. A., Virology 194, 20–27 (1993).
49. Huang, Y., Zhang, L., and Ho, D. D., J. Virol. 69, 93–100 (1995).(1989).
50. Delassus, S., Cheynier, R., and Wain-Hobson, S., J. Virol. 65, 225–40. Kimura, M., J. Mol. Evol. 16, 111–120 (1980).
231 (1991).41. Saitou, N., and Nei, M., Mol. Biol. Evol. 4, 402–425 (1987).
51. Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D.,42. Felsenstein, J., Evolution 39, 783–791 (1985).
and Greene, W. C., J. Virol. 69, 4112–4121 (1995).43. Thompson, J. D., Higgins, D. G., and Gibson, T. J., Nucleic Acids
52. Ratner, L., Starcich, B., Josephs, S. F., Hahn, B. H., Reddy, E. P.,Res. 22, 4673–4680 (1994).
Livak, K. J., Petteway, S. R., Pearson, M. L., Haseltine, W. A.,
44. Blumberg, B. M., Epstein, L. G., Saito, Y., Chen, D., Sharer, L. R.,
Arya, S. K., and Wong-Staal, F., Nucleic Acids Res. 13, 8219–
and Anand, R., J. Virol. 66, 5256–5264 (1992). 8229 (1985).
45. Michael, N. L., Chang, G., D’Arcy, L. A., Tseng, C. J., Birx, D. L., and 53. McNearney, T., Hornickova, Z., Markham, R., Birdwell, A., Arens,
Sheppard, H. W., J. Virol. 69, 6758–6769 (1995). M., Saah, A., and Ratner, L., Proc. Natl. Acad. Sci. USA 89,
46. Sawai, E. T., Baur, A. S., Peterlin, M., Levy, J. B., and Cheng-Mayer, 10247–10251 (1992).
C., J. Biol. Chem. 270, 1 –8 (1995). 54. Simmonds, P., Zhang, L. Q., McOmish, F., Balfe, P., Ludlam, C. A.,
47. Premkumar, D. R. D., Ma, X-C, Maitra, R. K., Chakrabarti, B. K., and Brown, A. J. L., J. Virol. 65, 6266–6276 (1991).
Salkowitz, J., Yen-Lieberman, B., Hirsch, M. S., and Kestler, 55. Mariani, R., and Skowronski, J., Proc. Natl. Acad. Sci. USA 90, 5549–
5553 (1993).H. W., AIDS Res. Hum. Retroviruses 12, 337–345 (1996).
AID VY 8098 / 6a1D$$$461 08-03-96 20:59:12 viras AP: Virology
